NexGard Spectra is a chewable tablet for dogs against the most common external and internal parasites of dogs. NexGard Spectra, in addition to its effect on external parasites, fights against helminths - roundworms, whipworms, hookworms, and also protects dogs from dirofilariasis.
Composition
1 g of the drug contains active ingredients: afoxolaner – 18.75 mg; milbemycin oxime – 3.75 mg; excipients.
Description
The drug is a tablet from light pink to dark pink, round or rectangular in shape. Available in five dosages (tablets of 0.5 g, 1 g, 2 g, 4 g, 8 g) packaged in blister packs of 3 tablets and packaged in cardboard boxes.
Storage conditions
Store the drug in closed original packaging at a temperature from 0 C to 30 C.
Application
Treatment of dog acarosis caused by ticks and fleas, treatment of dogs infected with gastrointestinal nematodes, complex therapy of allergic dermatitis, prevention of dirofilariasis in dogs.
Contraindications
Contraindication for use is the increased individual sensitivity of the animal to the active substances (components) of the drug. Do not use on sick or weakened animals. Do not use on puppies under 8 weeks of age and weighing up to 2 kg. Do not use on other animals except dogs.
Doses and order of administration
NexGard Spectra is administered orally, in a single dose of 2.5 – 5.36 mg (depending on the dog’s body weight) of afoxolaner and 0.5 – 1.07 mg of milbemycin oxime per 1 kg of animal body weight. For dogs weighing more than 60 kg, a combination of tablets of different weights is used. NexGard Spectra can be used as a seasonal flea and tick treatment (replacing monovalent treatment) in dogs with established gastrointestinal nematode infections. One-time use of the drug is effective in the treatment of gastrointestinal nematodes. After treatment of nematodes, the next treatment of animals against fleas and ticks is carried out with monovalent drugs. In order to prevent dirofilariasis in dangerous regions, NexGard Spectra is used monthly in the spring-summer-autumn period, starting a month before the start of summer, before the appearance of pathogen carriers - mosquitoes and mosquitoes, and is completed no earlier than a month after the end of summer. If the animal has been treated with another drug that protects against heartworms, the first application of NexGard Spectra should begin 1 month after the last treatment with the previous drug. Before treatment with the drug for the prevention of dirofilariasis, it is recommended to examine dogs over 8 months of age for the presence of mature dirofilariae in the body. Breaking tablets is not allowed. NexGard Spectra has a pleasant aroma and taste and, as a rule, is well eaten by dogs; otherwise, the drug is fed with food. It is necessary to make sure that the dog has completely swallowed the required dose of the drug.
